Literature DB >> 18609479

Characterization of idiopathic macular telangiectasia type 2 by fundus fluorescein angiography in Indian population.

R Narayanan1, A B Majji, N Hussain, A Hussain, S Jalali, A Mathai, V A Shah.   

Abstract

PURPOSE: To characterize the variations in fundus fluorescein angiography (FFA) features in idiopathic macular telangiectasia (IMT) type 2.
METHODS: Retrospective observational study. The authors included all the patients with IMT type 2 who underwent FFA during the period from January 2004 to December 2005. The main outcome measures were subretinal neovascularization and number and distance of telangiectasia from the center of the foveal avascular zone.
RESULTS: The mean age of 21 patients included in the study was 53.0+/-7.7 years. There were 11 women and 10 men. Six of the 21 patients had a history of diabetes mellitus. Subretinal neovascularization (SRN) was observed in 10 (23.8%) eyes. Subretinal plaque of pigment hyperplasia in the macula was found in 7 (21.9%) eyes, and crystalline yellowish deposits on the retinal surface were seen in 19 (59.4%) eyes. Only one eye had visible retinal telangiectasia. Most had more than 10 telangiectatic lesions in the macular area and the temporal macula was most commonly involved. The mean distance from the center of the foveal avascular zone (FAZ) up to which telangiectasia could be observed was 1340+/-400 microm. The maximum distance from the FAZ at which telangiectasia was identified was 2530 microm.
CONCLUSIONS: In IMT type 2, telangiectasia may be seen farther from the parafoveal area.

Entities:  

Mesh:

Year:  2008        PMID: 18609479     DOI: 10.1177/112067210801800414

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  7 in total

1.  Comparison of anatomical and visual outcomes following different anti-vascular endothelial growth factor treatments in subretinal neovascular membrane secondary to type 2 proliferative macular telangiectasia.

Authors:  Buğra Karasu; Betul Onal Gunay
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2019-11-25       Impact factor: 3.117

2.  Diagnosis of subretinal neovascularization associated with idiopathic juxtafoveal retinal telangiectasia - fluorescein angiography versus spectral-domain optical coherence tomography.

Authors:  Jay Chhablani; Kopal Mithal; Harsha Rao; Raja Narayanan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2013-10-23       Impact factor: 3.117

3.  Characteristics of retinal pigment clumps in Type 2 macular telangiectasia (MacTel).

Authors:  Ramesh Venkatesh; Sameeksha Agrawal; Nikitha Gurram Reddy; Pranjal Mishra; Deepashri Mutalik; Naresh Kumar Yadav; Jay Chhablani
Journal:  Eye (Lond)       Date:  2022-04-14       Impact factor: 3.775

4.  Multifocal electroretinography in type 2 idiopathic macular telangiectasia.

Authors:  Raja Narayanan; Vivek Dave; Padmaja K Rani; Jay Chhablani; Harsha B Rao; Rajeev R Pappuru; Subhadra Jalali
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-11-06       Impact factor: 3.117

5.  Efficacy of Intravitreal Bevacizumab in Treatment of Proliferative Type 2 Idiopathic Juxtafoveal Telangiectasia.

Authors:  Ökkeş Baz; İhsan Yılmaz; Cengiz Alagöz; Ali Demircan; İrfan Perente; Abdullah Özkaya; Muhittin Taşkapılı
Journal:  Turk J Ophthalmol       Date:  2017-06-01

6.  Relevance of Multicolor Imaging in Type 2 Macular Telangiectasia.

Authors:  Ramesh Venkatesh; Arpitha Pereira; Bharathi Bavaharan; Kushagra Jain; Aditya Aseem; Sajjan Sangai; Naresh Kumar Yadav
Journal:  J Curr Ophthalmol       Date:  2020-12-12

7.  Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization

Authors:  Müge Çoban Karataş; Gürsel Yılmaz; Aslıhan Yüce Sezen; Çağla Sarıtürk
Journal:  Turk J Ophthalmol       Date:  2022-02-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.